Searches across the literature and your internal assay data together, and every claim it makes carries the paper it came from.
Retrieves across published literature, trial registries and internal experiment records; distinguishes replicated findings from single-study results; states when the evidence is thin.
Retrieves across published literature, trial registries and internal experiment records; distinguishes replicated findings from single-study results; states when the evidence is thin.
const research = new NexusAgent({ role: 'research', corpora: ['pubmed', 'internal://assays'] });
const brief = await research.investigate({
question: 'Evidence for target X in fibrotic disease',
requireCitations: true
});
Published examples, reproduced verbatim. This page does not call a model.
Summarise the evidence for this target in idiopathic pulmonary fibrosis and tell me how much of it is replicated.
Fourteen relevant publications since 2019, plus three internal assay runs. Replicated: the expression increase in fibrotic tissue appears in four independent cohorts across three groups (citations attached), with consistent direction and effect size within a factor of two. This is solid. Single-source: the proposed mechanism rests on one 2022 paper. It has 90 citations, but I could find no independent replication of the knockdown result — the citing work largely repeats the claim rather than testing it. Treat the mechanism as a hypothesis. Contradicted: two of the three internal assay runs did not reproduce the published potency, at roughly a fifth of the reported effect. Worth understanding before this goes further. I am summarising evidence, not recommending a programme decision.